Clinical trial
ASCEND: A Study of Cardiovascular Events iN Diabetes
NCT00135226 · University of Oxford, Other · Active, not recruiting
Key facts
| NCT number | NCT00135226 |
|---|---|
| Title | ASCEND: A Study of Cardiovascular Events iN Diabetes |
| Official title | A Study of Cardiovascular Events iN Diabetes - A Randomized 2x2 Factorial Study of Aspirin Versus Placebo, and of Omega-3 Fatty Acid Supplementation Versus Placebo, for Primary Prevention of Cardiovascular Events in People With Diabetes |
| Lead sponsor | University of Oxford, Other |
| Collaborators | British Heart Foundation Bayer Industry Medical Research Council Solvay Pharmaceuticals Abbott Mylan Health Data Research UK Alzheimer's Research UK The Macular Society |
| Status | Active, not recruiting |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Aspirin, Omega-3 Ethyl Esters, Placebo Aspirin, Placebo Omega-3 Ethyl Esters |
| Enrollment | 15,480 |
| Start date | Mar 1, 2005 |
| Primary completion | Mar 12, 2018 |
| Completion | Jul 31, 2037 |
| First posted | Aug 25, 2005 |
| Last update posted | May 28, 2025 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: